Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials

Objective: To assess the best available evidence for efficacy of paracetamol (acetaminophen) in the treatment of osteoarthritis (OA). Design: Systematic review and meta-analysis of randomised controlled trials (RCTs). Data sources: Medline, Embase, Scientific Citation Index, CINAHL, Cochrane Library, and conference abstracts in the past 2 years from the British Society for Rheumatology, the European League Against Rheumatism, the American College of Rheumatology, and the Osteoarthritis Research Society International. Subjects: 10 RCTs including 1712 patients with either symptomatic OA of the knee (6 trials) or hip/knee (3 trials) or multiple joints (1 trial). Main outcome measures: (a) effect size (ES) for pain, stiffness, and functional scores from baseline to end point; (b) rate ratio (RR) and number needed to treat for clinical response rate and patient preference for treatment. Results: Paracetamol was effective in relieving pain due to OA (ES = 0.21, 95% confidence interval (CI) 0.02 to 0.41). Non-steroidal anti-inflammatory drugs (NSAIDs) were better than paracetamol for pain relief (ES = 0.20, 95% CI 0.10 to 0.30). Clinical response rate was higher with NSAIDs than with paracetamol (RR = 1.24, 95% CI 1.08 to 1.41), and the number of patients who preferred NSAIDs was more than twice the number of those preferring paracetamol (RR = 2.46, 95% CI 1.51 to 4.12). NSAIDs were associated with more frequent gastrointestinal discomfort than paracetamol (RR = 1.35, 95% CI 1.05 to 1.75). Conclusion: Paracetamol is an effective agent for pain relief due to OA. Although safer, it is less effective than NSAIDs. For safety reasons paracetamol should be the first line treatment, with NSAIDs reserved for those who do not respond.

[1]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[2]  J. Case,et al.  Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. , 2003, Archives of internal medicine.

[3]  E. Rahme,et al.  Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. , 2002, Arthritis and rheumatism.

[4]  S. Abramson.  Et tu, acetaminophen? , 2002, Arthritis and rheumatism.

[5]  M. Doherty,et al.  Key questions concerning paracetamol and NSAIDs for osteoarthritis , 2002, Annals of the rheumatic diseases.

[6]  J. Matthews,et al.  Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. , 2002, British journal of clinical pharmacology.

[7]  J. Hole,et al.  Analgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee. , 2002, British journal of clinical pharmacology.

[8]  P. Shekelle,et al.  A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. , 2002, The Journal of rheumatology.

[9]  Shu-chen Wu,et al.  Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. , 2002, Clinical therapeutics.

[10]  T. Schnitzer,et al.  Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. , 2002, JAMA.

[11]  Yun-Kyoung Song,et al.  Rheumatic pneumonia , 2001, Annals of the rheumatic diseases.

[12]  S. Hernández-Díaz,et al.  Relative Risk of Upper Gastrointestinal Complications among Users of Acetaminophen and Nonsteroidal Anti-Inflammatory Drugs , 2001, Epidemiology.

[13]  G. Koch,et al.  A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. , 2001, Arthritis and rheumatism.

[14]  K. Brandt,et al.  Severity of knee pain does not predict a better response to an antiinflammatory dose of ibuprofen than to analgesic therapy in patients with osteoarthritis. , 2001, The Journal of rheumatology.

[15]  R. McCarney,et al.  Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care , 2001, Annals of the rheumatic diseases.

[16]  R. Tallarida,et al.  Unexpected and pronounced antinociceptive synergy between spinal acetaminophen (paracetamol) and phentolamine. , 2001, European journal of pharmacology.

[17]  M. Dougados,et al.  EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2000, Annals of the rheumatic diseases.

[18]  J. Glowinski,et al.  Placebo-Controlled Study of the Analgesic Efficacy of a Paracetamol 500mg /Codeine 30mg Combination Together with Low-Dose vs High-Dose Diclofenac in Rheumatoid Arthritis , 1999 .

[19]  R. E. Boyd,et al.  Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. , 1999, The Journal of rheumatology.

[20]  E. Nelson,et al.  An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen , 1998, American Journal of Gastroenterology.

[21]  J. McCray,et al.  Clinical Endoscopic Evaluation of the Gastroduodenal Tolerance to (R)‐ Ketoprofen, (R)‐ Flurbiprofen, Racemic Ketoprofen, and Paracetamol: A Randomized, Single‐Blind, Placebo‐Controlled Trial , 1998, Journal of clinical pharmacology.

[22]  J. Reginster,et al.  Floctafenin versus acetaminophen for pain control in patients with osteoarthritis in the lower limbs. Franco-Belgian Task Force. , 1997, Revue du rhumatisme.

[23]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[24]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[25]  A. Po,et al.  Analgesic efficacy of paracetamol and its combination with codeine and caffeine in surgical pain–a meta‐analysis , 1996, Journal of clinical pharmacy and therapeutics.

[26]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[27]  D. Sackett,et al.  The number needed to treat: a clinically useful measure of treatment effect , 1995, BMJ.

[28]  L. March,et al.  n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis , 1994, BMJ.

[29]  P. Wolf,et al.  The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. , 1994, American journal of public health.

[30]  I. Russell,et al.  Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. , 1993, Arthritis and rheumatism.

[31]  P. Seideman,et al.  Naproxen and paracetamol compared with naproxen only in coxarthrosis. Increased effect of the combination in 18 patients. , 1993, Acta orthopaedica Scandinavica.

[32]  L. A. Kalasinski,et al.  Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. , 1992, The Journal of rheumatology.

[33]  C. Boissier,et al.  Acceptability and Efficacy of Two Associations of Paracetamol with a Central Analgesic (Dextropropoxyphene or Codeine): Comparison in Osteoarthritis , 1992, Journal of clinical pharmacology.

[34]  A Whitehead,et al.  A general parametric approach to the meta-analysis of randomized clinical trials. , 1991, Statistics in medicine.

[35]  K. Brandt,et al.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. , 1991, The New England journal of medicine.

[36]  L. Pedersen,et al.  Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study , 1990, Pain.

[37]  S. Laporte,et al.  Comparison in 141 outpatients with osteoarthritis of two combinations of paracetamol with a narcotic analgesic: a controlled clinical trial , 1990 .

[38]  P. Müller,et al.  [Endoscopic studies on the gastric tolerance of paracetamol and acetylsalicylic acid. A placebo-controlled, double-blind study in healthy volunteers]. , 1990, Arzneimittel-Forschung.

[39]  B. Amor,et al.  A method for comparing analgesics: glafenine and paracetamol. Multicenter cross-over approach. , 1988, Clinical rheumatology.

[40]  G. Vlok,et al.  Comparison of a standard ibuprofen treatment regimen with a new ibuprofen/paracetamol/codeine combination in chronic osteo-arthritis. , 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[41]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[42]  Larry V. Hedges,et al.  Fitting Continuous Models to Effect Size Data , 1982 .

[43]  Paul J. Vignos.  Osteoarthritis of the knee. , 1962, Arthritis and rheumatism.

[44]  P. Boston,et al.  Paracetamol plus metoclopramide ('Paramax') as an adjunct analgesic in the treatment of arthritis. , 1983, Current medical research and opinion.

[45]  S. Maneksha.  'Safapryn' and benorylate--a comparative trial of two new preparations of aspirin and paracetamol in the treatment of rheumatoid arthritis and osteoarthritis. , 1973, Current Medical Research and Opinion.

[46]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.